Opioid Use Disorder

Researchers have outlined consensus-based management strategies to guide clinicians who care for patients with cancer-associated pain and opioid misuse or opioid use disorder.

In Canada, the poorest residents were 3.8 times more likely to die of opioid-related causes than the country’s richest residents, a study published in Health Promotion and Chronic Disease Prevention in Canada showed.

In an effort to create a safer, more patient-friendly treatment system for opioid use disorder, providers and policymakers are analyzing shifting federal regulations and their potential impacts.

Simplifying the hepatitis C virus treatment process is essential to improving care among vulnerable populations, particularly people who inject drugs, according to experts.

The COVID-19 pandemic was a likely cause for worsened disparities in buprenorphine and naltrexone access for opioid use disorder among minority groups compared with white patients, per a study published in JAMA Network Open.

Following guideline updates for the treatment of opioid use disorder, pregnant women increasingly used buprenorphine compared with nonpregnant women.

Rural counties in the United States had lower odds of reaching maximum potential buprenorphine treatment capacity, according to findings published in Drug and Alcohol Dependence.

NEW ORLEANS —Educating third-year medical students on opioid use disorder and pain management helped prepare them for proper diagnosis and treatment, a speaker said at the American Psychiatric Association annual meeting.

Buprenorphine, a life-saving medication for opioid use disorder, is underutilized by physicians, according to researchers. 

Individuals with opioid use disorder and polysubstance use were less likely to initiate treatment with buprenorphine and naltrexone than those without polysubstance use, according to a study published in JAMA Network Open.